Table 1.
Clinicopathological variables.
| Clinicopathological variables | |
|---|---|
| Age (years) | |
| Mean | 45.18 |
|
| |
| Tumor size (cm) | |
| ≤2 cm | 13 |
| 2–5 cm | 18 |
| >5 cm | 5 |
|
| |
| Histopathological diagnosis | |
| IDC, NOS | 29 |
| Mucinous carcinoma | 2 |
| Metaplastic carcinoma | 1 |
| Medullary carcinoma | 3 |
| Mixed ductal-lobular carcinoma | 1 |
|
| |
| Tumor necrosis | |
| Present | 16 |
| Absent | 20 |
|
| |
| Margin | |
| Infiltrative | 25 |
| Pushing margin | 11 |
|
| |
| Lymphocytic infiltrate | |
| Present | 23 |
| Absent | 13 |
|
| |
| Tumor grade | |
| Grade I | 5 |
| Grade II | 17 |
| Grade III | 14 |
|
| |
| Lymph node metasatases | |
| Absent | 12 |
| 1 to 3 | 14 |
| >4 | 10 |
|
| |
| Tumour stage | |
| Stage I | 5 |
| Stage II | 16 |
| Stage III | 13 |
| Stage IV | 2 |
|
| |
| Ki-67 | |
| Positive | 29 |
| Negative | 7 |
|
| |
| Immunohistochemical panel | |
| CK5+ EGFR+ | 22 |
| CK5+ EGFR− | 5 |
| CK5− EGFR+ | 9 |
| CK5− EGFR− | Nil |